Evidence map›Paper›PMID 37767275›Full record

ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2023

Non-Invasive Zinc Protoporphyrin Screening Offers Opportunities for Secondary Prevention of Iron Deficiency in Blood Donors.

Anne Schliemann, Christian Homann, Georg Hennig, Alexander Lang, Lesca Miriam Holdt, Michael Vogeser, Ronald Sroka, Herbert Stepp, Franz Weinauer, Ernst-Markus Quenzel

Open access · goldAbstract read
In one paragraph

Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Anne SchliemannLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Christian HomannLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Georg HennigLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Alexander LangLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Lesca Miriam HoldtInstitute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.
Michael VogeserInstitute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.
Ronald SrokaLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Herbert SteppLaser Research Laboratory, LIFE Center, University Hospital, LMU Munich, Munich, Germany.
Franz WeinauerBlutspendedienst des Bayerischen Roten Kreuzes gemeinnützige GmbH, Munich, Germany.
Ernst-Markus QuenzelBlutspendedienst des Bayerischen Roten Kreuzes gemeinnützige GmbH, Munich, Germany.
LMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Frequent blood donors are at high risk of developing iron deficiency. Currently, there is no potent screening during blood donation to detect iron deficient erythropoiesis (IDE) before anemia develops and deferral from donation is inevitable. Study Design and Methods: In addition to capillary and venous hemoglobin, the iron status of 99 frequent blood donors was assessed by various venous blood parameters and zinc protoporphyrin IX (ZnPP). ZnPP was determined by high-performance liquid chromatography (HPLC) and a new prototype fiber-optic device was employed for non-invasive measurements of ZnPP through the blood collection tubing (NI-tubing) and on lip tissue (NI-lip). We aimed to evaluate the feasibility and diagnostic value of the NI-tubing measurement for early detection of severe iron deficiency in blood donors. Results: NI-tubing and HPLC reference measurements of ZnPP showed narrow limits of agreement of 12.2 μmol ZnPP/mol heme and very high correlation (Spearman's Rho = 0.938). Using a cutoff of 65 μmol ZnPP/mol heme, NI-tubing measurements ( Conclusion: NI-tubing measurements are an accurate and simple method to implement ZnPP determination into the routine blood donation process. ZnPP was able to identify the majority of subjects with IDE and IDA and might therefore be a valuable tool to provide qualified information to donors about dietary measures and adjustments of the donation interval and thereby help to prevent IDA and hemoglobin deferral in the future.

Indexed as

AnemiaBlood donationErythropoiesisIron deficiencyZinc protoporphyrin

Identifiers

PMID37767275
PMCPMC10521216
OpenAlexW4317861132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.